[1] PARK H Y, KOSMADAKI M, YAAR M, et al. Cellular mechanisms regulating human melanogenesis[J]. Cell Mol Life Sci, 2009, 66(9):1493-1506.
[2] LUCAS K, RAIKHEL A S. Insect microRNAs:Biogenesis, expression profiling and biological functions[J]. Insect Biochem Mol Biol, 2013, 43(1):24-38.
[3] WINTER J, JUNG S, KELLER S, et al. Many roads to maturity:microRNA biogenesis pathways and their regulation[J]. Nat Cell Biol, 2009, 11(3):228-234.
[4] YANG S S, FAN R W, SHI Z, et al. Identification of a novel microRNA important for melanogenesis in alpaca (Vicugna pacos)[J]. J Anim Sci, 2015, 93(4):1622-1631.
[5] WU D T, CHEN J S, CHANG D C, et al. Mir-434-5p mediates skin whitening and lightening[J]. Clin Cosmet Investig Dermatol, 2008, 1:19-35.
[6] ZHU Z W, HE J P, JIA X, et al. MicroRNA-25 functions in regulation of pigmentation by targeting the transcription factor MITF in Alpaca (Lama pacos) skin melanocytes[J]. Domest Anim Endocrinol, 2010, 38(3):200-209.
[7] GUO J, ZHANG J F, WANG W M, et al. MicroRNA-218 inhibits melanogenesis by directly suppressing microphthalmia-associated transcription factor expression[J]. RNA Biol, 2014, 11(6):732-741.
[8] DONG C S, WANG H D, XUE L L, et al. Coat color determination by miR-137 mediated down-regulation of microphthalmia-associated transcription factor in a mouse model[J]. RNA, 2012, 18(9):1679-1686.
[9] DYNOODT P, MESTDAGH P, VAN PEER G, et al. Identification of miR-145 as a key regulator of the pigmentary process[J]. J Invest Dermatol, 2013, 133(1):201-209.
[10] 张亚玲, 许冬梅, 杜斌, 等. 过表达miR-193b对黑色素细胞中MITF和TYR表达的影响[J]. 畜牧兽医学报, 2016, 47(5):938-943.
ZHANG Y L, XU D M, DU B, et al. The influences of over-expressing miR-193b on MITF and TYR in melanocytes[J]. Acta Veterinaria et Zootechnica Sinica, 2016, 47(5):938-943. (in Chinese)
[11] 曾庆宝, 范瑞文, 张秋月, 等. miR-324-3p通过调控MC1R基因影响黑色素的形成[J]. 畜牧兽医学报, 2016, 47(7):1381-1388.
ZENG Q B, FAN R W, ZHANG Q Y, et al. The effect of miR-324-3p on melanin synthesis via MC1R gene[J]. Acta Veterinaria et Zootechnica Sinica, 2016, 47(7):1381-1388. (in Chinese)
[12] BROZOVIC A. The relationship between platinum drug resistance and epithelial-mesenchymal transition[J]. Arch Toxicol, 2017, 91(2):605-619.
[13] QIU H J, YUAN S R, LU X H. miR-186 suppressed CYLD expression and promoted cell proliferation in human melanoma[J]. Oncol Lett, 2016, 12(4):2301-2306.
[14] SFONDRINI L, MORELLI D, BODINI A, et al. High level antibody response to retrovirus-associated but not to melanocyte lineage-specific antigens in mice protected against B16 melanoma[J]. Int J Cancer, 1999, 83(1):107-112.
[15] HORIKAWA T, NORRIS D A, YOHN J J, et al. Melanocyte mitogens induce both melanocyte chemokinesis and chemotaxis[J]. J Invest Dermatol, 1995, 104(2):256-259.
[16] CAO C H, SUN D G, ZHANG L, et al. miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1[J]. Oncotarget, 2016, 7(48):79956-79963.
[17] HUA X, XIAO Y, PAN W H, et al. miR-186 inhibits cell proliferation of prostate cancer by targeting GOLPH3[J]. Am J Cancer Res, 2016, 6(8):1650-1660.
[18] GALLARDO E, NAVARRO A, VIÑOLAS N, et al. miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer[J]. Carcinogenesis, 2009, 30(11):1903-1909.
[19] HEYN H, ENGELMANN M, SCHREEK S, et al. MicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer development[J]. Int J Cancer, 2011, 129(12):2797-2806.
[20] NAVARRO A, DIAZ T, MARTINEZ A, et al. Regulation of JAK2 by miR-135a:Prognostic impact in classic Hodgkin lymphoma[J]. Blood, 2009, 114(14):2945-2951.
[21] LANDGRAF P, RUSU M, SHERIDAN R, et al. A mammalian microRNA expression Atlas based on small RNA library sequencing[J]. Cell, 2007, 129(7):1401-1414.
[22] YAO K, HE L Y, GAN Y, et al. miR-186 suppresses the growth and metastasis of bladder cancer by targeting NSBP1[J]. Diagn Pathol, 2015, 10:146.
[23] GANGARAJU V K, LIN H F. MicroRNAs:Key regulators of stem cells[J]. Nat Rev Mol Cell Biol, 2009, 10(2):116-125.
[24] MANIKANDAN J, AARTHI J J, KUMAR S D, et al. Oncomirs:The potential role of non-coding microRNAs in understanding cancer[J]. Bioinformation, 2008, 2(8):330-334.
[25] IORIO M V, CROCE C M. microRNAs in cancer:Small molecules with a huge impact[J]. J Clin Oncol, 2009, 27(34):5848-5856.
[26] MELO S A, ESTELLER M. Dysregulation of microRNAs in cancer:Playing with fire[J]. FEBS Lett, 2011, 585(13):2087-2099.
[27] ORTHOLAN C, PUISSEGUR M P, ILIE M, et al. MicroRNAs and lung cancer:New oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets[J]. Curr Med Chem, 2009, 16(9):1047-1061.
[28] CHEN F, ZHOU C, LU Y X, et al. Expression of hsa-miR-186 and its role in human colon carcinoma cells[J]. J South Med Univ, 2013, 33(5):654-660.
[29] CAI J C, WU J H, ZHANG H Z, et al. miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation[J]. Cancer Res, 2013, 73(2):756-766.
[30] HE W, FENG J F, ZHANG Y, et al. microRNA-186 inhibits cell proliferation and induces apoptosis in human esophageal squamous cell carcinoma by targeting SKP2[J]. Lab Invest, 2016, 96(3):317-324.
[31] LIU Z Y, ZHANG G Q, YU W Z, et al. miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1[J]. Biochem Biophys Res Commun, 2016, 469(3):692-697.
[32] CARREIRA S, GOODALL J, DENAT L, et al. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness[J]. Genes Dev, 2006, 20(24):3426-3439.
[33] 刘铮铮. Waardenburg综合征Ⅱ型一家系的临床分析和MITF基因的突变检测[D]. 长沙:中南大学, 2007.
LIU Z Z. Clinical analysis of a Waardenburg syndrome type 2 family and mutation detection for MITF gene[D]. Changsha:Central South University, 2007. (in Chinese)
[34] 黎钊, 王平, 洪为松, 等. 正常人黑素细胞MITF对酪氨酸酶相关蛋白的转录调控研究[J]. 医学研究杂志, 2013, 42(3):58-62.
LI Z, WANG P, HONG W S, et al. Effect of MITF transcriptional control on family of tyrosinase-related proteins in normal human melanocytes[J]. Journal of Medical Research, 2013, 42(3):58-62. (in Chinese) |